curcumin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
curcumin — decreases glycated haemoglobin (HbA1c)
Evidence strength: moderate.Findingreplicated ×4“The means of diabetes-related blood chemistries used to assess diabetic progression, such as HbA1c, FPG, were significantly lower in the curcumin-treated group compared to the placebo group at visits at 3,6, 9, and 12 months (Table 2).”
Quoted verbatim from Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.. - Study
- RCT
- Dose
- curcuminoid extract 250 mg per capsule, three capsules twice daily (1500 mg curcuminoids a day) for 12 months
- Population
- Thai adults with recent type 2 diabetes, well controlled (HbA1c below 6.5%), BMI 23 or above, all on metformin; difference at 3, 6, 9 and 12 months (Table 2 shows p less than 0.05 at 12 months)
Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.2024PMID:3935448010.1186/s12937-024-01022-3Industry fundedPermalink
To cite this finding: https://catalystproject.ai/e/01M5RWZ0C7TEWSY1PH2GVZFAH3